help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deiber, M.
Right arrow Articles by Salle, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deiber, M.
Right arrow Articles by Salle, B.
Right arrowPubmed/NCBI databases
*Substance via MeSH

Journal of Clinical Endocrinology & Metabolism, Vol 68, 232-234, Copyright © 1989 by Endocrine Society


ARTICLES

Functional hypersomatotropism in small for gestational age (SGA) newborn infants

M Deiber, P Chatelain, D Naville, G Putet and B Salle
Department of Neonatology, Hopital Edouard Herriot, Lyon, France.

Basal plasma GH levels and the GH responses to an injection of 1 microgram/kg 1-44(NH2) GHRH were determined on day 3 postnatally in 5 small gestational age (SGA) twin newborns and their appropriate gestational age (AGA) co-twins, and in 10 SGA singleton newborns and 6 AGA singleton newborns. The mean basal plasma GH level was higher in the SGA than in the AGA infants but the difference was significant only for singleton newborns (p less than 0.01). The mean peak plasma GH level was markedly increased in SGA compared to AGA infants (p less than 0.05 for twins, p less than 0.01 for singletons). Twelve SGA infants re-tested at 1 month had lower basal and peak plasma GH levels (p less than 0.001 and p less than 0.01). In 21 SGA and 17 AGA infants, serum IGF-I, measured by RIA between 12 and 96 hours after birth, was significantly higher in SGA than in AGA (p less than 0.001). These results suggest that, whatever the mechanism, functional hypersomatotropism is present at day 3 in SGA infants. This hypersomatotropism may participate in the early catch-up growth process.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
P. Saenger, P. Czernichow, I. Hughes, and E. O. Reiter
Small for Gestational Age: Short Stature and Beyond
Endocr. Rev., April 1, 2007; 28(2): 219 - 251.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. J. De Blasio, K. L. Gatford, I. C. McMillen, J. S. Robinson, and J. A. Owens
Placental Restriction of Fetal Growth Increases Insulin Action, Growth, and Adiposity in the Young Lamb
Endocrinology, March 1, 2007; 148(3): 1350 - 1358.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. J. De Blasio, K. L. Gatford, J. S. Robinson, and J. A. Owens
Placental restriction of fetal growth reduces size at birth and alters postnatal growth, feeding activity, and adiposity in the young lamb
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R875 - R886.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
L B Johnston and M O Savage
Should recombinant human growth hormone therapy be used in short small for gestational age children?
Arch. Dis. Child., August 1, 2004; 89(8): 740 - 744.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Singhal, T. J. Cole, M. Fewtrell, J. Deanfield, and A. Lucas
Is Slower Early Growth Beneficial for Long-Term Cardiovascular Health?
Circulation, March 9, 2004; 109(9): 1108 - 1113.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
N.K. Arden, P. Major, J.R. Poole, R.W. Keen, S. Vaja, R. Swaminathan, C. Cooper, and T.D. Spector
Size at birth, adult intestinal calcium absorption and 1,25(OH)2 vitamin D
QJM, January 1, 2002; 95(1): 15 - 21.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
C. D Byrne
Programming other hormones that affect insulin: Type 2 diabetes
Br. Med. Bull., November 1, 2001; 60(1): 153 - 171.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. E. Muller, V. Locatelli, and D. Cocchi
Neuroendocrine Control of Growth Hormone Secretion
Physiol Rev, April 1, 1999; 79(2): 511 - 607.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. L. Ogilvy-Stuart, S. J. Hands, C. J. Adcock, J. M. P. Holly, D. R. Matthews, V. Mohamed-Ali, J. S. Yudkin, A. R. Wilkinson, and D. B. Dunger
Insulin, Insulin-Like Growth Factor I (IGF-I), IGF-Binding Protein-1, Growth Hormone, and Feeding in the Newborn
J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3550 - 3557.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
F. d. Zegher, I. Francois, m. van helvoirt, and g. van den berghe
Small as Fetus and Short as Child: From Endogenous to Exogenous Growth Hormone
J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2021 - 2026.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society